Effect of graft cell dose on second transplantation from a haploidentical donor with post-transplantation cyclophosphamide for relapsed/refractory acute leukemia

Bone Marrow Transplant. 2023 Aug;58(8):947-949. doi: 10.1038/s41409-023-01986-6. Epub 2023 Apr 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Cyclophosphamide / therapeutic use
  • Graft vs Host Disease*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukemia* / therapy
  • Leukemia, Myeloid, Acute* / therapy
  • Retrospective Studies
  • Transplantation Conditioning

Substances

  • Cyclophosphamide